A股異動 | 隴神戎發漲8% 生產75%乙醇消毒液獲批
格隆匯2月11日丨隴神戎發(300534.SZ)觸及漲停後回落,現報6.78元,漲幅8.02%,暫成交1.13億元,最新總市值20.8億。公司2月9日收到甘肅省衞生健康委員會《關於同意部分企業生產的消毒劑(第三批)用於疫情防控消毒使用的通告》,公司產品75%乙醇消毒液(經有效成分含量檢測合格)可以投入生產,主要用於疫情防控期間各類公共場所和醫療機構非重點診療區域的物體表面、餐飲具、排泄物、分泌物、屍體、污水等的消毒(參照產品標籤説明書)。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.